Disclosure Panels Details Page
T-Cell/Primary Cutaneous Lymphomas Panel - Disclosures as of 12/11/2018
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Weiyun Ai MD, PhD | Bristol Myers Squibb | ADT Therapeutics Bayer HealthCare More Health |
None | None | ✔ |
| Stephen Ansell MD, PhD | Bristol Myers Squibb Kyowa Hakko Kirin Co., Ltd. |
None | None | None | ✔ |
| Jeffrey Barnes MD, PhD | None | None | None | None | - |
| Mark Clemens MD | None | None | None | None | ✔ |
| Sarah DeVincenzo PharmD, BCPS | None | Decision Resources Group Consulting | None | None | - |
| Ahmet Dogan MD, PhD | None | Corvus Pharmaceuticals, Inc. Novartis Pharmaceuticals Corporation Oncology Specialty Group Peer Review Institute Roche Seattle Genetics |
Celgene Corporation Roche Pharmaceuticals |
None | - |
| Mary Dwyer MS | None | None | None | None | ✔ |
| Francine Foss MD | None | Spectrum Pharmaceuticals, Inc. | Seattle Genetics, Inc. | None | ✔ |
| Aaron Goodman MD | None | Jazz Pharmaceuticals Inc. TEMPUS |
Seattle Genetics, Inc. | None | - |
| Kristina Gregory MSN, RN | None | None | None | None | - |
| Joan Guitart MD | None | Actelion Pharmaceuticals US, Inc. | None | None | - |
| Ahmad Halwani MD | AbbVie, Inc. Amgen Inc. Bristol Myers Squibb Genentech, Inc. Immune Design Kyowa Hakko Kirin Co., Ltd. Millennium Pharmaceuticals, Inc. miragen Pharmacyclics Roche Laboratories, Inc. Seattle Genetics, Inc. |
None | None | None | ✔ |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | ✔ |
| Laura Hanisch PsyD | None | None | None | None | - |
| Bradley Haverkos MD, MPH, MS | None | None | Viracta Therapeutics | None | ✔ |
| Richard Hoppe MD | None | None | None | None | - |
| Steven Horwitz MD | ADC Therapeutics AILERON BeiGene Celgene Corporation Forty Seven, Inc. Kyowa Hakko Kirin Co., Ltd. Portola Pharmaceuticals, Inc. Seattle Genetics, Inc. Takeda/ Millennium TRILLIUM VERASTEM |
ADC Therapeutics AILERON Celgene Corporation Corvus Forty Seven, Inc. Innate Kyowa Hakko Kirin Co., Ltd. Miragen MUNDIPHARMA Portola Pharmaceuticals, Inc. Seattle Genetics, Inc. Takeda/Millennium TRILLIUM Verastem |
None | None | ✔ |
| Eric Jacobsen MD | None | Bayer HealthCare Merck & Co., Inc. Seattle Genetics |
None | None | - |
| Deepa Jagadeesh MD, MPH | Debiopharm International MEI Pharma Inc. Regeneron Pharmaceuticals, Inc. Seattle Genetics, Inc. |
None | None | None | ✔ |
| Ann Karosas RPh, BCOP | None | None | None | None | - |
| Youn Kim MD | Eisai Inc. Elorac Forty Seven, Inc. Galderma Horizon Innate Kyowa Hakko Kirin Co., Ltd. Merck & Co., Inc. miRagen Neumedicine Portola Pharmaceuticals, Inc. Soligenix Takeda Pharmaceuticals North America, Inc. Trillium |
Innate KHK Medivir Portola Pharmaceuticals, Inc. Seattle Genetics, Inc. Takeda Pharmaceuticals North America, Inc. |
None | None | ✔ |
| Matthew Lunning DO | Celgene Corporation Curis Janssen Pharmaceutica Products, LP Juno Therapeutics, Inc. TG Therapeutics |
AbbVie, Inc. AstraZeneca Pharmaceuticals LP Bayer HealthCare Cardinal Health Celgene Corporation Genentech, Inc. Gilead Sciences, Inc. Janssen Pharmaceutica Products, LP Kite Pharma Pharmacyclics Portola Pharmaceuticals, Inc. Seattle Genetics, Inc. Spectrum Pharmaceuticals, Inc. TG therapeutics Verastem |
None | None | - |
| Amitkumar Mehta MD | None | None | Aileron AstraZeneca Pharmaceuticals LP Bristol Myers Squibb Gilead Sciences Kite Pharmaceuticals Kyowa Hakko Kirin Co., Ltd. |
None | - |
| Neha Mehta-Shah MD, MSCI | Bristol Myers Squibb Celgene Corporation Genentech, Inc. Verastem |
Kyowa Hakko Kirin Co., Ltd. | None | None | - |
| Elise Olsen MD | Aclaris elorac Galderma |
Aclaris Bioniz Incyte Lilly |
None | None | - |
| Barbara Pro MD | Portola Pharmaceuticals, Inc. | Kyowa Hakko Kirin Co., Ltd. | Seattle Genetics, Inc. | None | ✔ |
| Saurabh Rajguru MD | None | None | None | None | - |
| Satish Shanbhag MBBS, MPH | Daiichi- Sankyo Co. | None | None | None | ✔ |
| Andrei Shustov MD | Bristol Myers Squibb Gilead Sciences, Inc. Kyowa Hakko Kirin Co., Ltd. Novartis Pharmaceuticals Corporation Seattle Genetics, Inc. Spectrum Pharmaceuticals, Inc. |
Kyowa Hakko Kirin Co., Ltd. | None | None | - |
| Lubomir Sokol MD, PhD | None | Mallinckrodt Seattle Genetics Spectrum |
Novartis Pharmaceuticals Corporation | None | ✔ |
| Hema Sundar PhD | None | None | None | None | ✔ |
| Pallawi Torka MD | None | None | None | None | ✔ |
| Carlos Torres-Cabala MD | None | None | None | None | - |
| Ryan Wilcox MD, PhD | Bristol Myers Squibb CTI BioPharma Corp. Incyte Corporation Kyowa Hakko Kirin Co., Ltd. Millennium Pharmaceuticals, Inc. Seattle Genetics, Inc. |
None | None | None | ✔ |
| Basem William MD, FACP | Celgene Corporation Innate Kite Pharma MIRAGEN National Cancer Institute |
Guidepoint advisors Navicor Triangle Insights Group |
None | None | ✔ |
| Jasmine Zain MD | None | AstraZeneca Pharmaceuticals LP BeiGene |
Seattle Genetics, Inc. | None | ✔ |